News | October 08, 2021
Lincoln Pharma gets Australian TGA approval
The company plans to expand its portfolio in regulated markets aggressively
The company plans to expand its portfolio in regulated markets aggressively
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
FUJIFILM will distribute iSWAB bio sampling technologies in Japan
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
The company does not expect the outcome of this inspection to impact its plans
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
The recipient is a 57-year-old woman who was suffering from severe biventricular heart failure and had undergone cardiac surgery several years ago
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
Subscribe To Our Newsletter & Stay Updated
